IP Library Granted Patent US 12,305,201
Granted Patent B2
US 12,305,201 · App. 18/344,690 · Granted May 20, 2025

Engineered biocatalysts and methods for synthesizing chiral amines

Inventors: Weng Lin Tang (Singapore, SG); Helen Hsieh (Singapore, SG); Son Pham (Singapore, SG); Derek Smith (Singapore, SG); Steven J. Collier (Concord, MA)
Assignee: Codexis, Inc.
C12N9/1096C12P13/001C12P15/00C12P17/12C12P17/188C12P33/00C12Y206/01
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,305,201
App. No.
18/344,690
Filed
Jun 29, 2023
Granted
May 20, 2025
Kind
B2
Art Unit
1656
USPC
435/119
Abstract

The present disclosure provides engineered transaminase polypeptides for the production of amines, polynucleotides encoding the engineered transaminases, host cells capable of expressing the engineered transaminases, and methods of using the engineered transaminases to prepare compounds useful in the production of active pharmaceutical agents.

Claims (26)

1. An engineered polypeptide having transaminase activity, wherein said engineered polypeptide comprises an amino acid sequence having at least 90% sequence identity to the amino acid sequence of SEQ ID NO: 2 and one or more residue differences as compared to SEQ ID NO:2 at residue positions selected from: X19, X34, X53, X73, X88, X107, X155, X165, X171, X178, X251, X259, X268, X277, X286, X312, X358, X366, X383, X399, X414, X426, and X450.

2. The engineered polypeptide of claim 1 , wherein said one or more amino acid residue differences as compared to SEQ ID NO: 2 are selected from X34A, X88H, X107G, X153C, X155V, X315G, X383I, and X450S.

3. The engineered polypeptide of claim 1 , wherein said engineered polypeptide comprises one or more amino acid residue differences as compared to SEQ ID NO:2 selected from X31M, X57F/L, X153A, and X383V.

4. The engineered polypeptide of claim 3 , wherein said engineered polypeptide comprises one or more amino acid residue differences as compared to SEQ ID NO:2 selected from X34A, X88A; X153C, X155V, X163F, and X315G.

5. The engineered polypeptide of claim 1 , wherein said engineered polypeptide comprises an amino acid residue difference as compared to SEQ ID NO:2 at position X316 selected from cysteine, phenylalanine, glycine, asparagine, serine and threonine.

6. The engineered polypeptide of claim 1 , wherein said engineered polypeptide comprises an amino acid residue difference as compared to SEQ ID NO:2 at position X323 of threonine.

7. The engineered polypeptide of claim 6 , wherein said engineered polypeptide comprises one or more amino acid residue differences as compared to SEQ ID NO:2 selected from X31M, X57F, X383I/T, and X450S.

8. The engineered polypeptide of claim 6 , wherein said amino acid differences as compared to SEQ ID NO:2 comprise a combination of amino acid residue differences selected from:

X31M, X57F, and X383V;

X31M, X57F, X107G, and X450S;

X31M, X57F, X233V, X383I, and X450S; and

X31M, X57F, X383I, and X450S.

9. The engineered polypeptide of claim 1 , wherein said engineered polypeptide has at least 1.2 fold increased stability as compared to the polypeptide of the amino acid sequence of SEQ ID NO: 4, wherein said engineered polypeptide comprises one or more amino acid residue differences as compared to SEQ ID NO:2 selected from X34T, X107G, X155V, X383I/V, and X450S.

10. The engineered polypeptide of claim 1 , wherein said engineered polypeptide has at least 1.2 fold increased stability as compared to the polypeptide of the amino acid sequence of SEQ ID NO: 4, wherein said engineered polypeptide comprises one or more amino acid residue differences as compared to SEQ ID NO:2 selected from X88H, and X153C.

11. The engineered polypeptide of claim 1 , wherein said engineered polypeptide has increased enantioselectivity as compared to the polypeptide of the amino acid sequence of SEQ ID NO: 4 in converting compound (2)

to compound (1),

wherein said engineered polypeptide comprises the amino acid residue differences as compared to SEQ ID NO:2 X57F and X153C.

12. The engineered polypeptide of claim 1 , wherein said engineered polypeptide comprises at least one amino acid residue difference as compared to SEQ ID NO:2 selected from: X18A, X19W, X31M, X34A, X53M, X57C/F/L, X73R, X88H/Y, X107G, X146L, X153A/C/V, X155A/V, X163L, X165F, X171Q, X178W, X190K, X206K, X228G, X235P, X244T, X251V, X259V, X268A, X277A, X286C/H, X312N, X314N, X315G, X319N, X358K, X366H, X383C/F/I/L/M/T/V, X395P, X399A, X424A, X426R, X427Y, and X450S.

13. The engineered polypeptide of claim 1 , wherein said engineered polypeptide does not comprise an amino acid residue difference as compared to SEQ ID NO:2 at positions corresponding to positions X9, X45, X177, X211, X294, X324, and X391.

14. The engineered polypeptide of claim 1 , wherein said engineered polypeptide is immobilized on a solid support.

15. The engineered polypeptide of claim 14 , wherein said solid support is a bead or resin comprising polymethacrylate with epoxide functional groups, polymethacrylate with amino epoxide functional groups, styrene/DVB copolymer or polymethacrylate with octadecyl functional groups.

16. An engineered polynucleotide encoding the engineered polypeptide of claim 1 .

17. An expression vector comprising the engineered polynucleotide of claim 16 .

18. A host cell comprising the expression vector of claim 17 .

19. A method of preparing an engineered polypeptide, comprising culturing the host cell of claim 18 , under conditions suitable for expression of said engineered polypeptide.

20. The method of claim 19 , further comprising isolating the engineered polypeptide.

Assignments (1)
SECURITY INTEREST Recorded Feb 15, 2024
From: CODEXIS, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT
Reel/Frame 066600/0650 →
Continuity (6)
Continuation 17317231 · May 11, 2021
Continuation 16701389 · Dec 3, 2019
Division 15869455 · Jan 12, 2018
Division 14652887
Provisional Application 61745219 · Dec 21, 2012
Related Publication 20230332115A1 · Oct 19, 2023
References Cited (126)
US 4518692A · Rozzell · 1985 [cited by applicant]
US 4600692A · Wood et al. · 1986 [cited by applicant]
US 4826766A · Rozzell · 1989 [cited by applicant]
US 4950606A · Stirling et al. · 1990 [cited by applicant]
US 5169780A · Stirling et al. · 1992 [cited by applicant]
US 5300437A · Stirling et al. · 1994 [cited by applicant]
US 5316943A · Kidman et al. · 1994 [cited by applicant]
US 6117679A · Stemmer · 2000 [cited by applicant]
US 6197558B1 · Fotheringham · 2001 [cited by applicant]
US 6376246B1 · Crameri et al. · 2002 [cited by applicant]
US 6537746B2 · Arnold et al. · 2003 [cited by applicant]
US 6586182B1 · Patten et al. · 2003 [cited by applicant]
US 9902943B2 · Tang et al. · 2018 [cited by applicant]
US 10435674B2 · Tang et al. · 2019 [cited by applicant]
US 10526587B2 · Tang et al. · 2020 [cited by applicant]
US 11034939B2 · Tang et al. · 2021 [cited by applicant]
US 20060195947A1 · Davis et al. · 2006 [cited by applicant]
US 20080213845A1 · Fotheringham et al. · 2008 [cited by applicant]
US 20080220990A1 · Fox · 2008 [cited by applicant]
US 20090312196A1 · Colbeck et al. · 2009 [cited by applicant]
US 20100209981A1 · Dhawan et al. · 2010 [cited by applicant]
US 20120041216A1 · Sieber et al. · 2012 [cited by applicant]
WO 9522625A1 · 1995 [cited by applicant]
WO 9533836A1 · 1995 [cited by applicant]
WO 9600787A1 · 1996 [cited by applicant]
WO 970078A1 · 1997 [cited by applicant]
WO 9735966A1 · 1997 [cited by applicant]
WO 9827230A1 · 1998 [cited by applicant]
WO 200042651A1 · 2000 [cited by applicant]
WO 200175767A2 · 2001 [cited by applicant]
WO 2005005633A2 · 2005 [cited by applicant]
WO 2008127646A2 · 2008 [cited by applicant]
WO 2009008908A2 · 2009 [cited by applicant]
WO 2010081053A2 · 2010 [cited by applicant]
WO 2011017551A1 · 2011 [cited by applicant]
WO 2011159910A2 · 2011 [cited by applicant]
WO 2013142770A1 · 2013 [cited by applicant]
Zhang M et al. Propagated Perturbations from a Peripheral Mutation Show Interactions Supporting WW Domain Thermostability. Structure. 2018. 26, 1474-1485. (Year: 2018). [cited by examiner]
Singh RK et al. Protein Engineering Approaches in the Post-Genomic Era. 2017. Current Protein and Peptide Science. 18, 1-11. ( Year: 2017). [cited by examiner]
Shin, J.S., et al., “Purification, characterization, and molecular cloning of a novel amine:pyruvate transaminase from Vibrio fluvialis JS17,” Appl. Microbiol. Biotechnol., 61(5-6):463-471 [2003]. [cited by applicant]
Simonen, M., et al., “Protein Secretion in [cited by applicant]
Smith, M., “In vitro mutagenesis,” Ann. Rev. Genet., 19:423-462 (1985). [cited by applicant]
Smith, T., et al., “Comparison of Biosequences,” Adv. Appl. Math, 2:482-489 (1981). [cited by applicant]
Stemmer, W., “DNA Shuffling by Random Fragmentation and Reassembly: In vitro Recombination for Molecular Evolution,” Proc. Natl. Acad. Sci. USA, 91:10747-10751 (1994). [cited by applicant]
Stemmer, W.P.C., “Rapid evolution of a protein in vitro by DNA shuffling”, Nature, 370:389-391 (1994). [cited by applicant]
Stenico, M., et al., “Codon usage in Caenorhabditis elegans: delineation of translational selection and mutational biases,” Nucl. Acids Res. 22(13): 2437-46 [1994]. [cited by applicant]
Streitwieser, Jr., A., et al., Introduction to Organic Chemistry, 2nd ed., pp. 169-171 (1981). [cited by applicant]
Suggs, S.V., et al., “Use of synthetic oligodeoxyribonucleotides for the isolation of specific cloned DNA sequenes,” In Developmental Biology Using Purified Genes (Brown et al., eds.), pp. 683-693, Academic Press (1981). [cited by applicant]
Tiwari, S., et al., “Prediction of probable genes by Fourier analysis of genomic sequences,” Comput. Appl. Biosci. 13(3):263-270 [1997]. [cited by applicant]
Truppo, M.D., et al., “Development of an Improved Immobilized CAL-B for the Enzymatic Resolution of a Key Intermediate to Odanacatib,” Organic Process Research & Development, 15:1033-1035 (2011). [cited by applicant]
Uberbacher, E.C., et al., “Discovering and Understanding Genes in Human DNA Sequence Using Grail,” Methods Enzymol., 266:259-281 [1996]. [cited by applicant]
Van Ophem, P.W., et al., “Substrate inhibition of D-amino acid transaminase and protection by salts and by reduced nicotinamide adenine dinucleotide: isolation and initial characterization of a pyridoxo intermediate rel… [cited by applicant]
Villa-Komaroff, L., et al., “A bacterial clone synthesizing proinsulin,” Proc. Natl Acad. Sci. USA, 75:3727-3731 (1978). [cited by applicant]
Wada, K., et al., “Codon usage tabulated from the GenBank genetic sequence data,” Nucl. Acids Res., 20:2111-2118 [1992]. [cited by applicant]
Wells, J.A., et al., “Cassette mutagenesis: an efficient method for generation of multiple mutations at defined sites,” Gene, 34:315-323 (1985). [cited by applicant]
Wetmur, J. G., “DNA Probes: Applications of the Principles of Nucleic Acid Hybridization,” Crit Rev Biochem Mol Biol, 26(3/4):227-259 (1991). [cited by applicant]
Wright, F., “The ‘effective number of codons’ used in a gene,” Gene 87:23-29 [1990]. [cited by applicant]
Yi, S., et al., “Covalent immobilization of omega-transaminase from Vibrio fluvialis JS17 on chitosan beads,” Process Biochemistry 42(5): 895-898 (2007). [cited by applicant]
Yonaha, K., et al., “Distribution of ω-Amino Acid : Pyruvate Transaminase and Aminobutyrate : α-Ketoglutarate Transaminase in Microorganisms,” Agric. Biol. Chem., 47 (10):2257-2265 [1983]. [cited by applicant]
Yun, H., et al., “Asymmetric synthesis of (S)-alpha-methylbenzylamine by recombinant [cited by applicant]
Yun, H., et al., “Kinetic resolution of (R,S)-sec-butylamine using omega-transaminase from Vibrio fluvialis JS17 under reduced pressure,” Biotechnol. Bioeng., 87:772-778 [2004]. [cited by applicant]
Yun, H., et al., “Use of Enrichment Culture for Directed Evolution of the Vibrio fluvialis JS17 omega-Transaminase, Which is Resistant to Product Inhibition by Aliphatic Ketones,” Appl Environ Microbiol., 71(8):4220-422… [cited by applicant]
Yun, H., et al., “ω-Amino Acid:Pyruvate Transaminase from Alcaligenes denitrificans Y2k-2: a New Catalyst for Kinetic Resolution of β-Amino Acids and Amines ,” Appl. Environ. Microbiol., 70:2529-2534 [2004]. [cited by applicant]
Zhang, J-H., et al., “Directed evolution of a fucosidase from a galactosidase by DNA shuffling and screening ,” Proc. Nat. Acad. Sci., U.S.A., 94:4504-4509 (1997). [cited by applicant]
Zhao, H., et al., “Molecular evolution by staggered extension process (StEP) in vitro recombination,” Nat. Biotechnol., 16:258-261 (1998). [cited by applicant]
Zhong, S., et al., “5-Chloro-7-iodo-8-quinolinolatomanganese(III) with the Feature of pH-Regulated Molecular Switches as a Highly Efficient Catalyst for Epoxidation of Olefins with Hydrogen Peroxide,” Adv. Synth. Catal.… [cited by applicant]
Zhu, D., et al., “Biocatalytic asymmetric amination of carbonyl functional groups—a synthetic biology approach to organic chemistry,” Biotechnol J., 4(10):1420-31 (2009). [cited by applicant]
Genbank Accession No. ABA47738.1 dated Jan. 31, 2014. [cited by applicant]
Genbank Accession No. AEA39183.1 dated Apr. 4, 2011. [cited by applicant]
Genbank Accession No. AM902716.1 dated Feb. 27, 2015. [cited by applicant]
NCBI Accession No. YP_002257813 dated Aug. 27, 2013. [cited by applicant]
Midelfort, K.S., et al., “Redesigning and characterizing the substrate specificity and activity of Vibrio fluvialis aminotransferase for the synthesis of imagabalin,” Protein Engineering Design and Selection, 26(1):25-3… [cited by applicant]
“Enzymatic synthesis of chiral amines with omega-transaminase,” IP.com Journal, IP.com Inc., West Henrietta, NY, US [Feb. 17, 2010]. [cited by applicant]
Georgescu, R., et al., “Saturation Mutagenesis” in Methods in Molecular Biology, vol. 231, pp. 75-81 [2003], Directed Evolution Library Creation: Methods and Protocols, Humana Press, Inc. [cited by applicant]
Zhang, M., et al., “Propagated Perturbations from a Peripheral Mutation Show Interactions Supporting WW Domain Thermostability,” Structure, 26:1474-1485 [2018]. [cited by applicant]
Singh, R.K., et al., “Protein Engineering Approaches in the Post-Genomic Era,” Current Protein and Peptide Science, 18:1-11 [2017]. [cited by applicant]
Altschul, S., et al., “Basic local alignment search tool,” J. Mol. Biol., 215: 403-410 (1990). [cited by applicant]
Altschul, S.F., et al., “Gapped Blast and PSI-Blast: a new generation of protein database search programs,” Nucleic Acids Res., 25(17):3389-3402 (1997). [cited by applicant]
Baldino, Jr., F., et al., “High-Resolution in Situ Hybridization Histochemistry,” Methods Enzymology, 168:761-777 (1989). [cited by applicant]
Batzer, M.A., “Erratum: Structure and variability of recently inserted Alu family members”, Nucleic Acids Res 19:698-699 [1991]. [cited by applicant]
Beaucage, S.L., et al., “Deoxynucleoside phosphoamidites—A new class of key intermediates for deoxypolynucleotide synthesis,” Tetrahedron Letters, 22(20):1859-62 (1981). [cited by applicant]
Black, M.E., et al., “Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy,” Proc Natl Acad Sci USA, 93:3525-3529 (1996). [cited by applicant]
Bolton, E.T., et al., “A General Method for the lisolation of RNA Complementary to DNA,” Proc. Natl. Acad. Sci. USA 48:1390 (1962). [cited by applicant]
Botstein, D., et al., “Strategies and applications of in vitro mutagenesis,” Science, 229(4719):1193-1201 [1985]. [cited by applicant]
Bray, P., et al., “Human cDNA clones for four species of [cited by applicant]
Caldwell, R.C., et al., “Mutagenic PCR,” PCR Methods Appl., 3:S136-S140 (1994). [cited by applicant]
Carey, F., Organic Chemistry, 2nd ed., pp. 328-331 [1992]. [cited by applicant]
Carter, P., “Site-directed mutagenesis,” Biochem. J., 237:1-7 (1986). [cited by applicant]
Cho, B.K., et al., “Redesigning the substrate specificity of omega-aminotransferase for the kinetic resolution of aliphatic chiral amines,” Biotechnol Bioeng. 99(2):275-84 [2008]. [cited by applicant]
Christians, F.C., et al., “Directed evolution of thymidine kinase for AZT phosphorylation using DNA family shuffling,” Nat. Biotechnol., 17:259-264 (1999). [cited by applicant]
Crameri, A., et al., “DNA shuffling of a family of genes from diverse species accelerates directed evolution”, Nature, 391:288-291 (1998). [cited by applicant]
Crameri, A., et al., “Improved green fluorescent protein by molecular evolution using DNA shuffling,” Nat. Biotechnol., 14(3):315-319 (1996). [cited by applicant]
Crameri, A., et al., “Molecular evolution of an arsenate detoxification pathway by DNA shuffling,” Nat. Biotechnol., 15 (5):436-438 (1997). [cited by applicant]
Dale, S.J., et al., “Oligonucleotide-directed random mutagenesis using the phosphorothioate method,” Methods Mol. Biol., 57:369-74 (1996). [cited by applicant]
De Boer, H.A., et al., “The tac promoter: A functional hybrid derived from the trp and lac promoters,” Proc. Natl Acad. Sci. USA, 80: 21-25 (1983). [cited by applicant]
Fasman, G.D.,CRC Practical Handbook of Biochemistry and Molecular Biology, CRC Press, Boca Raton, FL, pp. 3-70 [1989]. [cited by applicant]
Freier, S.M., et al., “Improved free-energy parameters for predictions of RNA duplex stability,” Proc. Natl. Acad. Sci USA, 83:9373-9377 (1986). [cited by applicant]
Guo, Z., et al., “3′-End-Forming Signals of Yeast mRNA,” Mol. Cell. Biol., 15(11):5983-5990 [1995]. [cited by applicant]
Henaut and Danchin in Neidhardt et al. [eds.], [cited by applicant]
Henikoff, S., et al., “Amino acid substitution matrices from protein blocks,” Proc. Natl. Acad. Sci., 89:10915-10919 (1992). [cited by applicant]
Höhne, M., et al., “Biocatalytic Routes to Optically Active Amines,” Chem. Cat. Chem., 1(1):42-51 [2009]. [cited by applicant]
Höhne, M., et al., “Efficient Asymmetric Synthesis of Chiral Amines by Combining Transaminase and Pyruvate Decarboxylase”, ChemBioChem, 9:363-365 (2008). [cited by applicant]
Hwang, B.-Y., et al., “High-throughput screening method for the identification of active and enantioselective ω-transaminases”, Enzyme and Microbial Technology, 34:429-436, 2004. [cited by applicant]
Iwasaki, A., et al., “Microbial synthesis of (R)- and (S)-3,4-dimethoxyamphetamines through stereoselective transamination,” Biotech. Lett., 25:1843-1846 [2003]. [cited by applicant]
Iwasaki, A., et al., “Microbial synthesis of chiral amines by (R)-specific transamination with [cited by applicant]
Kierzek, R., et al., “Polymer-Supported RNA Synthesis and Its Application to Test the Nearest-Neighbor Model for Duplex Stability,” Biochemistry, 25:7840-7846 (1986). [cited by applicant]
Koszelewski, D., et al., “Asymmetric Synthesis of Optically Pure Pharmacologically Relevant Amines Employing ω-Transaminases”, Adv. Synth. Catal., 350:2761-2766 (2008). [cited by applicant]
Koszelewski, D., et al., “Deracemization of mexiletine biocatalyzed by omega-transaminases,” Org. Lett., 11(21):4810-2 (2009). [cited by applicant]
Koszelewski, D., et al., “Immobilization of omega-transaminases by encapsulation in a sol-gel/celite matrix,” Journal of Molecular Catalysis B: Enzymatic, 63: 39-44 (2010). [cited by applicant]
Kramer, B., et al., “Different base/base mismatches are corrected with different efficiencies by the methyl-directed DNA mismatch-repair system of [cited by applicant]
Ling, M., et al., “Approaches to DNA Mutagenesis:An Overview,” Anal. Biochem., 254:157-78 (1997). [cited by applicant]
Martin, A.R., et al., “Characterization of free and immobilized (S)-aminotransferase for acetophenone production,” Applied Microbiology and Biotechnology, 76(4): 843-851 (2007). [cited by applicant]
Mateo, C., et al., “Epoxy sepabeads: a novel epoxy support for stabilization of industrial enzymes via very intense multipoint covalent attachment,” Biotechnology Progress 18(3):629-34 (2002). [cited by applicant]
Matthes, H.W.D., et al., “Simultaneous rapid chemical synthesis of over one hundred oligonucleotides on a microscale,” EMBO J., 3(4):801-05 (1984). [cited by applicant]
McInerney, J.O., “GCUA: general codon usage analysis,” Bioinformatics, 14(4):372-73 [1998]. [cited by applicant]
Minshull, J., et al., “Protein evolution by molecular breeding,” Curr. Op. Chem. Biol., 3(3):284-290 (1999). [cited by applicant]
Nakamura, Y., et al., “Codon usage tabulated from international DNA sequence databases: status for the year 2000,” Nucl. Acids Res., 28:292 [2000]. [cited by applicant]
Needleman, S., et al., “A general method applicable to the search for similarities in the amino acid sequence of two proteins,” J. Mol. Biol. 48:443-453 (1970). [cited by applicant]
Pearson, W.R., “Improved tools for biological sequence comparison,” Proc. Nat'l. Acad. Sci. USA, 85:2444-2448 (1988). [cited by applicant]
Romanos, M.A., et al., “Foreign gene expression in yeast: a review,” Yeast 8:423-488 [1992]. [cited by applicant]
Rychlik, W., et al., “Optimization of the annealing temperature for DNA amplification in vitro,” Nucleic Acids Res, 18 (21):6409-6412 (1990). [cited by applicant]
Shin, J.S., et al., “Asymmetric synthesis of chiral amines with omega-transaminase,” Biotechnol. Bioeng. 65(2): 206-211 [1999]. [cited by applicant]
Shin, J.S., et al., “Comparison of the omega-transaminases from different microorganisms and application to production of chiral amines,” Biosci. Biotechnol. Biochem. 65:1782-1788 (2001). [cited by applicant]
Shin, J.S., et al., “Exploring the active site of amine:pyruvate aminotransferase on the basis of the substrate structure-reactivity relationship: how the enzyme controls substrate specificity and stereoselectivity,” J.… [cited by applicant]
Shin, J.S., et al., “Kinetic resolution of alpha-methylbenzylamine with omicron-transaminase screened from soil microorganisms: application of a biphasic system to overcome product inhibition,” Biotechnol. Bioeng. 55(2)… [cited by applicant]
Shin, J.S., et al., “Kinetic resolution of chiral amines with omega-transaminase using an enzyme-membrane reactor,” Biotechnol Bioeng, 73(3):179-187 [2001]. [cited by applicant]